Central Nervous System (CNS) Therapeutic Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Central Nervous System (CNS) Therapeutic Market to 2027 - Global Analysis and Forecasts by Disease Type (Neurovascular Diseases, Degenerative Disorders, Mental Health, Trauma, Others); Drug Type (Analgesics, Nervous System Drugs, Anesthetics, Anti-Parkinson Drugs, Anti-Epileptics, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies) and Geography

Report Code: TIPRE00004069 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system drugs and others are used in the treatment for these diseases.

MARKET DYNAMICS
The central nervous system (CNS) therapeutic market is anticipated to grow due to the key driving factors such as increasing prevalence of neurological disorders, increase in adoption of new-generation drugs and growing awareness regarding psychiatric disorders across the globe. However, rapidly growing geriatric population which is leading to an increase in the number of neurological disease cases is likely to grow the market during the forecast period.

MARKET SCOPE
The "Global Central Nervous System (CNS) Therapeutic Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of central nervous system (CNS) therapeutic market with detailed market segmentation by disease type, drug type and distribution channel. The global central nervous system (CNS) therapeutic market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading central nervous system (CNS) therapeutic market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global central nervous system (CNS) therapeutic market is segmented on the basis of disease type, drug type and distribution channel. On the basis of disease type, the market is segmented as, neurovascular diseases, degenerative disorders, mental health, trauma and others. Based on drug type, the market is categorized as analgesics, nervous system drugs, anesthetics, Anti-Parkinson drugs, anti-epileptics and others. On the basis of distribution channel, the central nervous system (CNS) therapeutic market is segmented as, hospitals pharmacies and retail pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global central nervous system (CNS) therapeutic market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The central nervous system (CNS) therapeutic market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting central nervous system (CNS) therapeutic market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the central nervous system (CNS) therapeutic market in these regions.

MARKET PLAYERS
The reports cover key developments in the central nervous system (CNS) therapeutic market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from central nervous system (CNS) therapeutic market are anticipated to lucrative growth opportunities in the future with the rising demand for central nervous system (CNS) therapeutic market in the global market. Below mentioned is the list of few companies engaged in the central nervous system (CNS) therapeutic market.

The report also includes the profiles of key central nervous system (CNS) therapeutic market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Eli Lilly and Company
  • Pfizer Inc.
  • Otsuka America Pharmaceutical, Inc.
  • Biogen
  • Merck & Co., Inc.
  • AstraZeneca
  • Novartis AG
  • Shire (Takeda)
  • Teva Pharmaceutical Industries Ltd.
  • Johnson & Johnson Services, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Central Nervous System (CNS) Therapeutic Market - By Disease Type
1.3.2 Central Nervous System (CNS) Therapeutic Market - By Drug Type
1.3.3 Central Nervous System (CNS) Therapeutic Market - By Distribution Channel
1.3.4 Central Nervous System (CNS) Therapeutic Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - GLOBAL MARKET ANALYSIS
6.1. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC - GLOBAL MARKET OVERVIEW
6.2. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. NEUROVASCULAR DISEASES
7.3.1. Overview
7.3.2. Neurovascular Diseases Market Forecast and Analysis
7.4. DEGENERATIVE DISORDERS
7.4.1. Overview
7.4.2. Degenerative Disorders Market Forecast and Analysis
7.5. MENTAL HEALTH
7.5.1. Overview
7.5.2. Mental Health Market Forecast and Analysis
7.6. TRAUMA
7.6.1. Overview
7.6.2. Trauma Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
8.1. OVERVIEW
8.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
8.3. ANALGESICS
8.3.1. Overview
8.3.2. Analgesics Market Forecast and Analysis
8.4. NERVOUS SYSTEM DRUGS
8.4.1. Overview
8.4.2. Nervous System Drugs Market Forecast and Analysis
8.5. ANESTHETICS
8.5.1. Overview
8.5.2. Anesthetics Market Forecast and Analysis
8.6. ANTI-PARKINSON DRUGS
8.6.1. Overview
8.6.2. Anti-Parkinson Drugs Market Forecast and Analysis
8.7. ANTI-EPILEPTICS
8.7.1. Overview
8.7.2. Anti-Epileptics Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
10. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Central Nervous System (CNS) Therapeutic Market Overview
10.1.2 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.1.3 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.1.4 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.1.5 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.1.6.1 United States Central Nervous System (CNS) Therapeutic Market
10.1.6.1.1 United States Central Nervous System (CNS) Therapeutic Market by Disease Type
10.1.6.1.2 United States Central Nervous System (CNS) Therapeutic Market by Drug Type
10.1.6.1.3 United States Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.1.6.2 Canada Central Nervous System (CNS) Therapeutic Market
10.1.6.2.1 Canada Central Nervous System (CNS) Therapeutic Market by Disease Type
10.1.6.2.2 Canada Central Nervous System (CNS) Therapeutic Market by Drug Type
10.1.6.2.3 Canada Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.1.6.3 Mexico Central Nervous System (CNS) Therapeutic Market
10.1.6.3.1 Mexico Central Nervous System (CNS) Therapeutic Market by Disease Type
10.1.6.3.2 Mexico Central Nervous System (CNS) Therapeutic Market by Drug Type
10.1.6.3.3 Mexico Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Central Nervous System (CNS) Therapeutic Market Overview
10.2.2 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.2.3 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.2.4 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.2.5 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Central Nervous System (CNS) Therapeutic Market
10.2.6.1.1 Germany Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.1.2 Germany Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.1.3 Germany Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.2 France Central Nervous System (CNS) Therapeutic Market
10.2.6.2.1 France Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.2.2 France Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.2.3 France Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.3 Italy Central Nervous System (CNS) Therapeutic Market
10.2.6.3.1 Italy Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.3.2 Italy Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.3.3 Italy Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.4 Spain Central Nervous System (CNS) Therapeutic Market
10.2.6.4.1 Spain Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.4.2 Spain Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.4.3 Spain Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.5 United Kingdom Central Nervous System (CNS) Therapeutic Market
10.2.6.5.1 United Kingdom Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.5.2 United Kingdom Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.5.3 United Kingdom Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Overview
10.3.2 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.3.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.3.4 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.3.5 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Central Nervous System (CNS) Therapeutic Market
10.3.6.1.1 Australia Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.1.2 Australia Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.1.3 Australia Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.2 China Central Nervous System (CNS) Therapeutic Market
10.3.6.2.1 China Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.2.2 China Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.2.3 China Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.3 India Central Nervous System (CNS) Therapeutic Market
10.3.6.3.1 India Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.3.2 India Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.3.3 India Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.4 Japan Central Nervous System (CNS) Therapeutic Market
10.3.6.4.1 Japan Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.4.2 Japan Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.4.3 Japan Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.5 South Korea Central Nervous System (CNS) Therapeutic Market
10.3.6.5.1 South Korea Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.5.2 South Korea Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.5.3 South Korea Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Overview
10.4.2 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.4.3 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.4.4 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.4.5 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Central Nervous System (CNS) Therapeutic Market
10.4.6.1.1 South Africa Central Nervous System (CNS) Therapeutic Market by Disease Type
10.4.6.1.2 South Africa Central Nervous System (CNS) Therapeutic Market by Drug Type
10.4.6.1.3 South Africa Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.4.6.2 Saudi Arabia Central Nervous System (CNS) Therapeutic Market
10.4.6.2.1 Saudi Arabia Central Nervous System (CNS) Therapeutic Market by Disease Type
10.4.6.2.2 Saudi Arabia Central Nervous System (CNS) Therapeutic Market by Drug Type
10.4.6.2.3 Saudi Arabia Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.4.6.3 U.A.E Central Nervous System (CNS) Therapeutic Market
10.4.6.3.1 U.A.E Central Nervous System (CNS) Therapeutic Market by Disease Type
10.4.6.3.2 U.A.E Central Nervous System (CNS) Therapeutic Market by Drug Type
10.4.6.3.3 U.A.E Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Central Nervous System (CNS) Therapeutic Market Overview
10.5.2 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.5.3 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.5.4 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.5.5 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Central Nervous System (CNS) Therapeutic Market
10.5.6.1.1 Brazil Central Nervous System (CNS) Therapeutic Market by Disease Type
10.5.6.1.2 Brazil Central Nervous System (CNS) Therapeutic Market by Drug Type
10.5.6.1.3 Brazil Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.5.6.2 Argentina Central Nervous System (CNS) Therapeutic Market
10.5.6.2.1 Argentina Central Nervous System (CNS) Therapeutic Market by Disease Type
10.5.6.2.2 Argentina Central Nervous System (CNS) Therapeutic Market by Drug Type
10.5.6.2.3 Argentina Central Nervous System (CNS) Therapeutic Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET, KEY COMPANY PROFILES
12.1. ELI LILLY AND COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. OTSUKA AMERICA PHARMACEUTICAL, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIOGEN
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO., INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVARTIS AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SHIRE (TAKEDA)
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. JOHNSON AND JOHNSON SERVICES, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Eli Lilly and Company
2. Pfizer Inc.
3. Otsuka America Pharmaceutical, Inc.
4. Biogen
5. Merck & Co., Inc.
6. AstraZeneca
7. Novartis AG
8. Shire (Takeda)
9. Teva Pharmaceutical Industries Ltd.
10. Johnson & Johnson Services, Inc.